Lantheus Holdings, Inc. (LNTH)
99.95
-0.24
(-0.24%)
USD |
NASDAQ |
Oct 06, 16:00
99.97
+0.02
(+0.02%)
After-Hours: 20:00
Lantheus Holdings Enterprise Value : 6.555B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 6.555B |
| October 05, 2026 | 6.571B |
| October 02, 2026 | 6.556B |
| October 01, 2026 | 6.535B |
| September 30, 2026 | 6.527B |
| September 29, 2026 | 6.526B |
| September 28, 2026 | 6.541B |
| September 25, 2026 | 6.541B |
| September 24, 2026 | 6.540B |
| September 23, 2026 | 6.556B |
| September 22, 2026 | 6.558B |
| September 21, 2026 | 6.576B |
| September 18, 2026 | 6.594B |
| September 17, 2026 | 6.610B |
| September 16, 2026 | 6.593B |
| September 15, 2026 | 6.606B |
| September 14, 2026 | 6.579B |
| September 11, 2026 | 6.574B |
| September 10, 2026 | 6.584B |
| September 09, 2026 | 6.604B |
| September 08, 2026 | 6.587B |
| September 04, 2026 | 6.621B |
| September 03, 2026 | 6.622B |
| September 02, 2026 | 6.611B |
| September 01, 2026 | 6.616B |
| Date | Value |
|---|---|
| August 31, 2026 | 6.621B |
| August 28, 2026 | 6.608B |
| August 27, 2026 | 6.589B |
| August 26, 2026 | 6.612B |
| August 25, 2026 | 6.615B |
| August 24, 2026 | 6.610B |
| August 21, 2026 | 6.556B |
| August 20, 2026 | 6.574B |
| August 19, 2026 | 6.589B |
| August 18, 2026 | 6.575B |
| August 17, 2026 | 6.618B |
| August 14, 2026 | 6.620B |
| August 13, 2026 | 6.620B |
| August 12, 2026 | 6.606B |
| August 11, 2026 | 6.603B |
| August 10, 2026 | 6.622B |
| August 07, 2026 | 6.620B |
| August 06, 2026 | 6.628B |
| August 05, 2026 | 6.656B |
| August 04, 2026 | 6.631B |
| August 03, 2026 | 6.636B |
| July 31, 2026 | 6.535B |
| July 30, 2026 | 6.623B |
| July 29, 2026 | 6.558B |
| July 28, 2026 | 6.730B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biomerica, Inc. | 7.913M |
| Univec, Inc. | 6.272M |
| Indivior Pharmaceuticals, Inc. | 4.523B |
| Zomedica Corp. | 35.21M |
| Bristol Myers Squibb Co. | 155.73B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 75.03M |
| Revenue (Quarterly) | 388.18M |
| Total Expenses (Quarterly) | 313.15M |
| EPS Diluted (Quarterly) | 1.111 |
| Gross Profit Margin (Quarterly) | 62.30% |
| Profit Margin (Quarterly) | 19.33% |
| Earnings Yield | 4.14% |
| Operating Earnings Yield | 4.53% |
| Normalized Earnings Yield | 4.172 |